NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 197 filers reported holding NEVRO CORP in Q3 2021. The put-call ratio across all filers is 2.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $355,608 | +3.5% | 18,502 | +36.8% | 0.00% | 0.0% |
| Q2 2023 | $343,703 | -93.7% | 13,521 | -71.0% | 0.00% | -87.5% |
| Q3 2021 | $5,433,000 | -29.5% | 46,680 | +0.4% | 0.01% | -33.3% |
| Q2 2021 | $7,711,000 | +58.3% | 46,507 | +33.2% | 0.01% | +50.0% |
| Q1 2021 | $4,872,000 | -59.2% | 34,922 | -49.4% | 0.01% | -61.9% |
| Q4 2020 | $11,945,000 | +60.5% | 69,008 | +29.2% | 0.02% | +40.0% |
| Q3 2020 | $7,441,000 | +260.9% | 53,422 | +209.5% | 0.02% | +275.0% |
| Q2 2020 | $2,062,000 | – | 17,260 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 403,424 | $46,950,000 | 6.74% |
| HealthCor Management, L.P. | 529,230 | $61,592,000 | 2.66% |
| Sante Capital Fund, LP | 18,963 | $2,207,000 | 2.04% |
| Jackson Square Partners, LLC | 2,452,497 | $285,421,000 | 1.81% |
| Altium Capital Management LP | 51,000 | $5,935,000 | 1.56% |
| Rock Springs Capital Management LP | 635,700 | $73,983,000 | 1.56% |
| PFM Health Sciences, LP | 392,786 | $45,712,000 | 1.34% |
| Redmile Group, LLC | 542,932 | $63,186,000 | 1.10% |
| Connacht Asset Management LP | 13,555 | $1,578,000 | 1.02% |
| Integral Health Asset Management, LLC | 30,000 | $3,491,000 | 1.00% |